FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157769495> ?p ?o ?g. }

• W3157769495 endingPage "63" @default.
• W3157769495 startingPage "55" @default.
• W3157769495 abstract "ObjectiveTo report the intra-operative adverse events (IOAEs) and the initial and one year outcomes of retrograde open mesenteric stenting (ROMS) using balloon expandable covered stents for acute and chronic mesenteric ischaemia.MethodsClinical data and outcomes of all consecutive patients treated with ROMS for acute and chronic mesenteric ischaemia at an intestinal stroke centre between November 2012 and September 2019 were reviewed. ROMS was performed using balloon expandable covered stents. Endpoints included IOAEs, in hospital mortality, post-operative complications, and re-interventions. One year overall survival, freedom from re-intervention, primary patency and assisted primary patency rates were analysed using the Kaplan–Meier time to event method.ResultsDuring the study period, 379 patients were referred to the centre for acute or chronic mesenteric ischaemia. Thirty-seven patients who underwent the ROMS procedure were included. All the patients had severe atherosclerotic mesenteric lesions. The ROMS technical success rate was 89% in this cohort. The rate of IOAEs was 19% and included four cases of retrograde recanalisation failure. All ROMS failures occurred in patients presenting with flush superior mesenteric artery occlusion and they were treated by mesenteric bypass. Ten patients (27%) underwent bowel resection, four of which resulted in a short bowel syndrome (11%). The in hospital mortality rate was 27%. Post-operative complications and re-intervention rates were 67% (n = 25) and 32% (n = 12), respectively. The median follow up was 20.2 months (interquartile range 29). The estimated one year overall survival for the cohort was 70.1% (95% confidence interval [CI] 52.5% – 82.2%). The estimated freedom from re-intervention at one year was 61.1% (95% CI 42.3 – 75.4). The one year primary patency and assisted primary patency rates were 84.54% (95% CI 63.34 – 94) and 92.4% (95% CI 72.8 – 98), respectively.ConclusionROMS procedures offer acceptable one year outcomes for mesenteric ischaemia but are associated with frequent stent related complications. Precise pre-operative planning, high quality imaging, and meticulous stent placement techniques may limit the occurrence of such events. To report the intra-operative adverse events (IOAEs) and the initial and one year outcomes of retrograde open mesenteric stenting (ROMS) using balloon expandable covered stents for acute and chronic mesenteric ischaemia. Clinical data and outcomes of all consecutive patients treated with ROMS for acute and chronic mesenteric ischaemia at an intestinal stroke centre between November 2012 and September 2019 were reviewed. ROMS was performed using balloon expandable covered stents. Endpoints included IOAEs, in hospital mortality, post-operative complications, and re-interventions. One year overall survival, freedom from re-intervention, primary patency and assisted primary patency rates were analysed using the Kaplan–Meier time to event method. During the study period, 379 patients were referred to the centre for acute or chronic mesenteric ischaemia. Thirty-seven patients who underwent the ROMS procedure were included. All the patients had severe atherosclerotic mesenteric lesions. The ROMS technical success rate was 89% in this cohort. The rate of IOAEs was 19% and included four cases of retrograde recanalisation failure. All ROMS failures occurred in patients presenting with flush superior mesenteric artery occlusion and they were treated by mesenteric bypass. Ten patients (27%) underwent bowel resection, four of which resulted in a short bowel syndrome (11%). The in hospital mortality rate was 27%. Post-operative complications and re-intervention rates were 67% (n = 25) and 32% (n = 12), respectively. The median follow up was 20.2 months (interquartile range 29). The estimated one year overall survival for the cohort was 70.1% (95% confidence interval [CI] 52.5% – 82.2%). The estimated freedom from re-intervention at one year was 61.1% (95% CI 42.3 – 75.4). The one year primary patency and assisted primary patency rates were 84.54% (95% CI 63.34 – 94) and 92.4% (95% CI 72.8 – 98), respectively. ROMS procedures offer acceptable one year outcomes for mesenteric ischaemia but are associated with frequent stent related complications. Precise pre-operative planning, high quality imaging, and meticulous stent placement techniques may limit the occurrence of such events." @default.
• W3157769495 created "2021-05-10" @default.
• W3157769495 creator A5003599014 @default.
• W3157769495 creator A5019032438 @default.
• W3157769495 creator A5034524361 @default.
• W3157769495 creator A5043730074 @default.
• W3157769495 creator A5054273602 @default.
• W3157769495 creator A5055690147 @default.
• W3157769495 creator A5078829240 @default.
• W3157769495 creator A5083875385 @default.
• W3157769495 date "2021-07-01" @default.
• W3157769495 modified "2023-10-12" @default.
• W3157769495 title "Retrograde Open Mesenteric Stenting for Acute and Chronic Mesenteric Ischaemia: Results from an Intestinal Stroke Centre" @default.
• W3157769495 cites W19271014 @default.
• W3157769495 cites W1963955180 @default.
• W3157769495 cites W1964633982 @default.
• W3157769495 cites W1967008976 @default.
• W3157769495 cites W1989225884 @default.
• W3157769495 cites W2020301331 @default.
• W3157769495 cites W2020843949 @default.
• W3157769495 cites W2035045305 @default.
• W3157769495 cites W2068502485 @default.
• W3157769495 cites W2073286020 @default.
• W3157769495 cites W2082117389 @default.
• W3157769495 cites W2090099381 @default.
• W3157769495 cites W2132540187 @default.
• W3157769495 cites W2139612107 @default.
• W3157769495 cites W2139937737 @default.
• W3157769495 cites W2161142575 @default.
• W3157769495 cites W2467122689 @default.
• W3157769495 cites W2592245751 @default.
• W3157769495 cites W2602285456 @default.
• W3157769495 cites W2790538374 @default.
• W3157769495 cites W2911473996 @default.
• W3157769495 cites W2963833027 @default.
• W3157769495 cites W2984166941 @default.
• W3157769495 doi "https://doi.org/10.1016/j.ejvs.2021.03.019" @default.
• W3157769495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33965329" @default.
• W3157769495 hasPublicationYear "2021" @default.
• W3157769495 type Work @default.
• W3157769495 sameAs 3157769495 @default.
• W3157769495 citedByCount "4" @default.
• W3157769495 countsByYear W31577694952021 @default.
• W3157769495 countsByYear W31577694952023 @default.
• W3157769495 crossrefType "journal-article" @default.
• W3157769495 hasAuthorship W3157769495A5003599014 @default.
• W3157769495 hasAuthorship W3157769495A5019032438 @default.
• W3157769495 hasAuthorship W3157769495A5034524361 @default.
• W3157769495 hasAuthorship W3157769495A5043730074 @default.
• W3157769495 hasAuthorship W3157769495A5054273602 @default.
• W3157769495 hasAuthorship W3157769495A5055690147 @default.
• W3157769495 hasAuthorship W3157769495A5078829240 @default.
• W3157769495 hasAuthorship W3157769495A5083875385 @default.
• W3157769495 hasBestOaLocation W31577694951 @default.
• W3157769495 hasConcept C119060515 @default.
• W3157769495 hasConcept C126322002 @default.
• W3157769495 hasConcept C127413603 @default.
• W3157769495 hasConcept C141071460 @default.
• W3157769495 hasConcept C2776696333 @default.
• W3157769495 hasConcept C2777785015 @default.
• W3157769495 hasConcept C2780645631 @default.
• W3157769495 hasConcept C2781046184 @default.
• W3157769495 hasConcept C541997718 @default.
• W3157769495 hasConcept C71924100 @default.
• W3157769495 hasConcept C72563966 @default.
• W3157769495 hasConcept C78519656 @default.
• W3157769495 hasConceptScore W3157769495C119060515 @default.
• W3157769495 hasConceptScore W3157769495C126322002 @default.
• W3157769495 hasConceptScore W3157769495C127413603 @default.
• W3157769495 hasConceptScore W3157769495C141071460 @default.
• W3157769495 hasConceptScore W3157769495C2776696333 @default.
• W3157769495 hasConceptScore W3157769495C2777785015 @default.
• W3157769495 hasConceptScore W3157769495C2780645631 @default.
• W3157769495 hasConceptScore W3157769495C2781046184 @default.
• W3157769495 hasConceptScore W3157769495C541997718 @default.
• W3157769495 hasConceptScore W3157769495C71924100 @default.
• W3157769495 hasConceptScore W3157769495C72563966 @default.
• W3157769495 hasConceptScore W3157769495C78519656 @default.
• W3157769495 hasIssue "1" @default.
• W3157769495 hasLocation W31577694951 @default.
• W3157769495 hasOpenAccess W3157769495 @default.
• W3157769495 hasPrimaryLocation W31577694951 @default.
• W3157769495 hasRelatedWork W2032949453 @default.
• W3157769495 hasRelatedWork W2364927694 @default.
• W3157769495 hasRelatedWork W2388368713 @default.
• W3157769495 hasRelatedWork W2403281239 @default.
• W3157769495 hasRelatedWork W2417887856 @default.
• W3157769495 hasRelatedWork W2468170508 @default.
• W3157769495 hasRelatedWork W2928707686 @default.
• W3157769495 hasRelatedWork W3014824666 @default.
• W3157769495 hasRelatedWork W3118377219 @default.
• W3157769495 hasRelatedWork W4281742514 @default.
• W3157769495 hasVolume "62" @default.
• W3157769495 isParatext "false" @default.
• W3157769495 isRetracted "false" @default.
• W3157769495 magId "3157769495" @default.
• W3157769495 workType "article" @default.